— Know what they know.
Not Investment Advice
Also trades as: SHIEF (OTC) · $vol 0M

STX.L LSE

Shield Therapeutics plc
1W: +14.4% 1M: +7.2% 3M: -2.5% YTD: -44.6% 1Y: -26.5% 3Y: -43.3% 5Y: -86.5%
£6.00 ($0.08)
-0.05 (-0.83%)
 
Weekly Expected Move ±12.0%
£5 £5 £6 £7 £7
LSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 63 · £63.6M mcap · 409M float · 0.590% daily turnover
#4 of 7
Drug Manufacturers - Specialty & Generic
Healthcare · Micro Cap · 6 peers
Market Share
0.2%
Top 4 Concentration: 99.8%

Peer Comparison

Symbol Mkt Cap P/E ROE % ROIC % Net Mgn % Rev Grw % Piotroski Signal 1Y Ret %
STX.L Shield Therapeutics plc $60M -8.0 321.4 2603.7 -7.4 302.1 4 BULLISH -26.5
EAH.L ECO Animal Health Group plc $70M 30.3 4.4 10.0 -0.9 2.0 7 BULLISH 33.6
HIK.L Hikma Pharmaceuticals PLC $4.4B 11.6 31.4 22.1 12.9 15.3 7 BEARISH -14.3
PXS.L Provexis plc $20M -44.8 -83.5 -141.0 -57.9 156.6 2 BEARISH 33.3
ABTI Alterola Biotech, Inc. — -0.1 -27.4 216.7 — — 3 BEARISH 0.0
AGY.L Allergy Therapeutics plc $760M -4.8 -551.0 -244.2 -54.9 -3.7 1 BEARISH -40.6
HLN.L Haleon plc $39B 18.1 9.6 7.4 13.6 -1.3 8 BEARISH -9.4

Profile Radar

Valuation vs Profitability

Performance Comparison

Industry Market Share

STX.L vs Benchmarks

ROIC
STX.L
2603.7
Industry
-0.8
Gross Margin
STX.L
58.1
Industry
44.9
Op Margin
STX.L
0.7
Industry
-19.3
Net Margin
STX.L
-7.4
Industry
-24.6
Sector
-157.4
Revenue Growth
STX.L
302.1
Sector
0.8
P/E Ratio
STX.L
-8.0
Sector
17.0
ROE
STX.L
321.4
Sector
-70.3
Piotroski F
STX.L
4.0
Sector
3.0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms